Suppr超能文献

使用双特异性抗体和适用于正电子发射断层扫描免疫闪烁成像的镓螯合物在裸鼠中进行多步骤肿瘤靶向。

Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography.

作者信息

Schuhmacher J, Klivényi G, Matys R, Stadler M, Regiert T, Hauser H, Doll J, Maier-Borst W, Zöller M

机构信息

Department of Diagnostic and Therapeutic Radiology (FS5), German Cancer Research Center, Heidelberg.

出版信息

Cancer Res. 1995 Jan 1;55(1):115-23.

PMID:7805020
Abstract

To improve tumor:tissue ratios in immunoscintigraphy, a three-step targeting method has been developed. The reagents used were (a) a radioactive, low molecular weight chelate prepared from ionic gallium and a phenolic polyaminocarboxylic acid, which can be labeled either with the single-photon emitter 67Ga or with the short-lived positron emitter 68Ga (t1/2 = 68 min); (b) a bispecific monoclonal antibody (bs-mAb) synthesized from the F(ab)2 fragment of the 1.1ASML antibody specific for the glycoprotein CD44v associated with a rat pancreas carcinoma cell line and the F(ab') fragment of an antibody specific for the gallium chelate; and (c) the nonradioactive gallium chelate covalently coupled to transferrin, which served as a high molecular weight blocker to prevent binding of the radioactive gallium chelate to bs-mAbs in the circulation. Targeting experiments in tumor-bearing nude mice with different doses of bs-mAbs, blocker, and 67Ga chelate were adjusted to maximize tumor to tissue contrasts and tumor uptake. Compared with the biodistribution of the 131I-labeled, native 1.1ASML antibody 24 h postinjection, a schedule using 100 pmol bs-mab 24 h later 100 pmol blocker, 15 min later 16 pmol 67Ga chelate, 1 h later examination, increased tumor:blood and tumor: liver ratios by a factor of 5 while keeping the localization of radioactivity in the tumor constant (10.1% injected dose/g). High-contrast images using either 67Ga or 68Ga were obtained within 1 h. The targeting method described enables the use of the short-lived positron emitter 68Ga and thus allows the combination of an improved immunoscintigraphy and positron emission tomography.

摘要

为提高免疫闪烁显像中的肿瘤与组织比值,已开发出一种三步靶向方法。所使用的试剂包括:(a) 一种由离子镓和酚类聚氨基羧酸制备的放射性低分子量螯合物,其可用单光子发射体67Ga或短寿命正电子发射体68Ga(半衰期t1/2 = 68分钟)进行标记;(b) 一种双特异性单克隆抗体(bs-mAb),由针对与大鼠胰腺癌细胞系相关的糖蛋白CD44v的1.1ASML抗体的F(ab)2片段和针对镓螯合物的抗体的F(ab')片段合成;(c) 与转铁蛋白共价偶联的非放射性镓螯合物,用作高分子量阻断剂,以防止放射性镓螯合物在循环中与bs-mAb结合。在荷瘤裸鼠中进行靶向实验,对不同剂量的bs-mAb、阻断剂和67Ga螯合物进行调整,以最大化肿瘤与组织的对比度和肿瘤摄取。与注射后24小时的131I标记的天然1.1ASML抗体的生物分布相比,一种方案是在24小时后使用100 pmol bs-mab,100 pmol阻断剂,15分钟后使用16 pmol 67Ga螯合物,1小时后进行检查,这使得肿瘤与血液以及肿瘤与肝脏的比值提高了5倍,同时保持肿瘤中放射性的定位不变(注射剂量的10.1%/克)。使用67Ga或68Ga均可在1小时内获得高对比度图像。所描述的靶向方法能够使用短寿命正电子发射体68Ga,从而实现改进的免疫闪烁显像与正电子发射断层扫描的联合应用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验